The European healthcare technology (HealthTech) mergers and acquisitions (M&A) landscape has entered a period of structured recalibration. Following post-pandemic market adjustments, current M&A activity reflects a structural transition away from speculative growth toward high-conviction, disciplined transactions. Capital deployment is heavily concentrated in platforms demonstrating clear operational leverage, defensible reimbursement pathways, and deep technological moats.
Nelson Advisors
Jul 25
Add a title here. Make it bold and impactful. Click to edit.
Nelson Advisors specialise in Mergers and Acquisitions for European HealthTech, MedTech, Digital Health, Healthcare IT, Healthcare AI companies in the Lower to Mid Market ranging from $25M to $250M EV.
